Molecular and cellular mechanisms of pharmacoresistance in epilepsy
- PMID:16317026
- DOI: 10.1093/brain/awh682
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
Abstract
Epilepsy is a common and devastating neurological disorder. In many patients with epilepsy, seizures are well-controlled with currently available anti-epileptic drugs (AEDs), but a substantial (approximately 30%) proportion of patients continue to have seizures despite carefully optimized drug treatment. Two concepts have been put forward to explain the development of pharmacoresistance. The transporter hypothesis contends that the expression or function of multidrug transporters in the brain is augmented, leading to impaired access of AEDs to CNS targets. The target hypothesis holds that epilepsy-related changes in the properties of the drug targets themselves may result in reduced drug sensitivity. Recent studies have started to dissect the molecular underpinnings of both transporter- and target-mediated mechanisms of pharmacoresistance in human and experimental epilepsy. An emerging understanding of these underlying molecular and cellular mechanisms is likely to provide important impetus for the development of new pharmacological treatment strategies.
Similar articles
- [Drug resistance in epilepsy].Czuczwar P, Kaczmarczyk K, Wierzchowska-Cioch E, Łuszczki JJ, Czuczwar SJ.Czuczwar P, et al.Przegl Lek. 2009;66(11):963-6.Przegl Lek. 2009.PMID:20297639Review.Polish.
- Plasticity of antiepileptic drug targets.Beck H.Beck H.Epilepsia. 2007;48 Suppl 1:14-8. doi: 10.1111/j.1528-1167.2007.00994.x.Epilepsia. 2007.PMID:17316408Review.
- Intranasal anticonvulsive treatment: a prospective management of intractable epilepsy?Tan L, Yu JT, Guan HS.Tan L, et al.Med Hypotheses. 2008 Oct;71(4):542-5. doi: 10.1016/j.mehy.2008.05.022. Epub 2008 Jul 9.Med Hypotheses. 2008.PMID:18614291
- Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy.Schaub C, Uebachs M, Beck H.Schaub C, et al.Epilepsia. 2007 Jul;48(7):1339-50. doi: 10.1111/j.1528-1167.2007.01103.x. Epub 2007 Apr 18.Epilepsia. 2007.PMID:17441992
- [Mechanisms of drug resistance in epilepsy].Lasoń W.Lasoń W.Przegl Lek. 2006;63(11):1218-20.Przegl Lek. 2006.PMID:17348420Review.Polish.
Cited by
- Concise review: prospects of stem cell therapy for temporal lobe epilepsy.Shetty AK, Hattiangady B.Shetty AK, et al.Stem Cells. 2007 Oct;25(10):2396-407. doi: 10.1634/stemcells.2007-0313. Epub 2007 Jun 28.Stem Cells. 2007.PMID:17600108Free PMC article.Review.
- A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy.Naimo GD, Guarnaccia M, Sprovieri T, Ungaro C, Conforti FL, Andò S, Cavallaro S.Naimo GD, et al.Int J Mol Sci. 2019 Jul 30;20(15):3717. doi: 10.3390/ijms20153717.Int J Mol Sci. 2019.PMID:31366017Free PMC article.Review.
- Frontline Sodium Channel-Blocking Antiseizure Medicine Use Promotes Future Onset of Drug-Resistant Chronic Seizures.Zierath D, Mizuno S, Barker-Haliski M.Zierath D, et al.Int J Mol Sci. 2023 Mar 2;24(5):4848. doi: 10.3390/ijms24054848.Int J Mol Sci. 2023.PMID:36902275Free PMC article.
- Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies.Yang CS, Wu MC, Lai MC, Wu SN, Huang CW.Yang CS, et al.Int J Mol Sci. 2023 Aug 24;24(17):13143. doi: 10.3390/ijms241713143.Int J Mol Sci. 2023.PMID:37685950Free PMC article.Review.
- The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature.Chen P, Yan Q, Xu H, Lu A, Zhao P.Chen P, et al.Genet Test Mol Biomarkers. 2014 Feb;18(2):106-11. doi: 10.1089/gtmb.2013.0362. Epub 2013 Dec 10.Genet Test Mol Biomarkers. 2014.PMID:24325761Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical